IsoRay Receives FDA Response to 510(k) Application for GammaTile(TM)

Additional Testing for GammaTile™ Planned for Completion by Year-End 2017 RICHLAND, Wash., July 6, 2017 -- (Healthcare Sales & Marketing Network) -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medi... Devices, Oncology, FDA IsoRay, GammaTile, radiotherapy, brachytherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news